Skip to content
Case report Open access

Case Report: Infantile hypercalcemia type 1 due to CYP24A1 pathogenic variants—three adult patients with nephrolithiasis and nephrocalcinosis successfully treated with fluconazole

Sep 2026 · Frontiers in Medicine · Vol 13 · 0 citations · 16 references
Medicine

TL;DR

This case series highlights rare late-onset manifestations of HCINF1 associated with recurrent nephrolithiasis, secondary distal renal tubular acidosis (dRTA), and variable degrees of renal function impairment and supports the therapeutic role of fluconazole in selected cases.

Abstract

Infantile hypercalcemia type 1 (HCINF1) is a rare genetic disorder caused by pathogenic variants in the CYP24A1 gene, which encodes the vitamin D–catabolic enzyme 24-hydroxylase responsible for inactivating 1,25-dihydroxyvitamin D₃. The clinical presentation ranges from severe forms diagnosed in infancy—characterized by hypercalcemia, dehydration, and vomiting—to milder forms that are often identified in adulthood during evaluation for recurrent nephrolithiasis. We present two adult female patients with late-onset HCINF1, both initially referred to a nephrologist for nephrolithiasis and nephrocalcinosis, and one male patient with an infantile presentation who began fluconazole therapy in adulthood. This case series highlights rare late-onset manifestations of HCINF1 associated with recurrent nephrolithiasis, secondary distal renal tubular acidosis (dRTA), and variable degrees of renal function impairment. It emphasizes the importance of considering genetic testing in adults with unexplained hypercalcemia and nephrolithiasis and supports the therapeutic role of fluconazole in selected cases.

Read PDF

Similar papers

Case report Open access Oct 2026

Adult presentation of SLC29A3-related disorder spectrum with marked hypogammaglobulinemia due to a recurrent homozygous pathogenic variant (G437R): a case report

Background SLC29A3-related disorder spectrum encompasses rare autosomal recessive conditions characterized by multisystem involvement, including immunodeficiency, lymphoproliferation, cutaneous findings, endocrine dysfunction, and growth failure. The clinical presentation is highly heterogeneous, often leading to delay...

M. Ishqair, Abbas K. H. Masalma, M. Saleh et al. · 0 citations
Case report Open access Oct 2026

Familial Hypomagnesemia With Hypercalciuria and Nephrocalcinosis: A Case Report of Compound Heterozygous Variants in the CLDN16 Gene Inherited From Symptomatic Heterozygous Carriers

Abstract Introduction Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is a rare autosomal recessive disorder characterized by renal magnesium wasting, hypercalciuria, and early onset of nephrocalcinosis, complicated by progressive chronic renal failure in childhood or adolescence. The disorder...

M. Ceol, Elena Sgrò, F. Anglani et al. · 0 citations
Case report Open access Oct 2026

Co-occurrence of pathogenic CYP24A1 gene variants and primary hyperparathyroidism: a diagnostic challenge

Abstract Hypercalcemia is mostly caused by primary hyperparathyroidism (PHPT) or malignancy. Less commonly, hypercalcemia results from vitamin D-dependent mechanisms. Pathogenic variants in CYP24A1, which encodes the 24-hydroxylase responsible for inactivating 1,25(OH)2D3, can lead to hypercalciuria, nephrolithiasis/ne...

S. Della Valentina, L. Pierotti, C. Sardella et al. · 0 citations
Open access Sep 2026

CORTICAL-PREDOMINANT NEPHROCALCINOSIS AS AN EARLY RADIOLOGIC MARKER OF FULMINANT INFANTILE PRIMARY HYPEROXALURIA TYPE 1: A CASE REPORT

Background: Primary hyperoxaluria type 1 (PH1) is a rare autosomal recessive disorder of glyoxylate metabolism leading to hepatic oxalate overproduction, progressive nephrocalcinosis, and early end-stage renal disease (ESRD), particularly in its severe infantile form. Early radiological recognition is critical for prom...

Brahim El Mahjoub, Wiame Bougrine, H. O. Chahdi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.